NOVN — Novartis AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Novartis AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11,293	28,113	18,726	14,073	13,351
Net Total Accounts Receivable
Net Total Receivables	10,036	9,621	9,894	9,376	9,539
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29,673	45,718	36,910	30,481	29,704
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13,939	13,106	12,195	10,924	10,873
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	127,778	131,795	117,453	99,945	102,246
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,059	30,208	28,656	26,390	28,692
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	71,180	64,140	58,111	53,278	58,200
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	56,598	67,655	59,342	46,667	44,046
Total Liabilities & Shareholders' Equity	127,778	131,795	117,453	99,945	102,246
Total Common Shares Outstanding